Despite a recent drop, Zhangzhou Pientzehuang Pharmaceutical's long-term returns remain impressive. The market sentiment remains steady, reflecting the EPS growth. The current sell-off could be an opportunity if sustainable growth continues.

Zhangzhou Pientzehuang Pharmaceutical's performance is commendable, with efficient reinvestment of its earnings leading to impressive earnings growth. The company's earnings growth is expected to continue at a similar rate, according to analyst forecasts.

Zhangzhou Pientzehuang Pharmaceutical investors remain upbeat despite high P/E ratio. However, comfort is wavering due to the difficulty of justifying these prices long-term without substantial growth rate improvements.

Zhangzhou Pientzehuang Pharmaceutical's share price reflects steady EPS growth indicating investor sentiment continuity. It appears that shareholders are rewarded generously via dividends, as suggested by total shareholder returns exceeding share price return.